Evotec AG (NASDAQ:EVTCY) | Finanzwire

Basculer en Français

8302	Companies
115121	Keywords
55446	Articles
62530	Press releases

Home
Companies
Evotec AG

BRIEF

published on 07/08/2024 at 14:05, 4 months 13 days ago

Just – Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz

Partnership Biosimilars Evotec Sandoz Biologics
PRESS RELEASE

published on 07/08/2024 at 14:00, 4 months 13 days ago

Just – Evotec Biologics expands tech partnership for biosimilars with Sandoz
Evotec SE's biologics segment, Just - Evotec Biologics, expands partnership for biosimilars with Sandoz, securing long-term commercial supply. Collaboration aims for cost-efficient development

Evotec SE Biosimilars Just - Evotec Biologics Sandoz Commercial Supply
BRIEF

published on 06/25/2024 at 07:35, 4 months 26 days ago

Just-Evotec Biologics Selected by U.S. DOD for Manufacturing Optimization

Evotec SE Biologics Manufacturing U.S. Department Of Defense Monoclonal Antibodies Medical Countermeasures
PRESS RELEASE

published on 06/25/2024 at 07:30, 4 months 26 days ago

Just – Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program
Just \/ Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program. Evotec SE subsidiary chosen for $39m accelerated mAb development project

Evotec SE Just - Evotec Biologics U.S. Department Of Defense Manufacturing Optimization Program MAb Development
BRIEF

published on 06/12/2024 at 07:35, 5 months 9 days ago

Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb

Collaboration Neuroscience Evotec Neurodegenerative Diseases Bristol Myers Squibb
PRESS RELEASE

published on 06/12/2024 at 07:30, 5 months 9 days ago

Evotec announces progress in neuroscience collaboration with Bristol Myers Squibb
Evotec SE makes progress in neuroscience collaboration with Bristol Myers Squibb, receiving a US$20m research payment. The partnership focuses on developing treatments for neurodegenerative diseases

Evotec SE Neurodegenerative Diseases Bristol Myers Squibb Neuroscience Collaboration Research Payment
BRIEF

published on 06/10/2024 at 18:05, 5 months 11 days ago

Evotec SE: Results of the Annual General Meeting 2024

Shareholders Supervisory Board Evotec Approval AGM 2024
PRESS RELEASE

published on 06/10/2024 at 18:00, 5 months 11 days ago

Evotec SE: Results of the Annual General Meeting 2024
Evotec SE shareholders approve most proposals at the Annual General Meeting 2024. Dr Duncan McHale and Wesley Wheeler elected to the Supervisory Board, replacing Dr Elaine Sullivan and Dr Mario Polywka

Annual General Meeting Shareholders Evotec SE Supervisory Board Business Performance
BRIEF

published on 05/30/2024 at 07:35, 5 months 22 days ago

Evotec Collaborates to Uncover New Therapeutic Targets in Obesity and Metabolic Diseases

Metabolic Diseases Evotec Obesity Therapeutic Targets PanOmics Technologies
PRESS RELEASE

published on 05/30/2024 at 07:30, 5 months 22 days ago

Evotec, Inserm, Lille University Hospital and Inserm Transfert enter collaboration to identify novel therapeutic targets in obesity and metabolic diseases
Evotec partners with Inserm, Lille University Hospital & Inserm Transfert to identify therapeutic targets in obesity & metabolic diseases. Collaboration to leverage PanOmics technologies

Metabolic Diseases Evotec Obesity Inserm Lille University Hospital

Accesswire

Published on 11/21/2024 at 22:05, 1 hour 6 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 1 hour 21 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 2 hours 56 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 3 hours 1 minute ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 20:00, 3 hours 11 minutes ago

Victory for New York Homeowners: Petroff Amshen LLP Blocks Lender’s Repeated Foreclosure Attempt

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 4 hours 10 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 4 hours 35 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 5 hours 13 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 5 hours 20 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 5 hours 20 minutes ago

2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.

Les Echos

Published on 11/21/2024 at 06:58, 16 hours 13 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 3 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 5 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 5 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 15 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE